Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress towards an amebiasis vaccine.

S L Stanley1

  • 1Department of Medicine and Molecular Microbiology, Washington University School of Medicine, Campus Box 8051, 660 South Euclid Avenue, St Louis, MO 63110, USA. sstanlet@visar.wustl.edu

Parasitology Today (Personal Ed.)
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating gene signals from noisy microarray images.

IEEE transactions on nanobioscience·2008
Same author

Vaccines for amoebiasis: barriers and opportunities.

Parasitology·2007
Same author

Blockade of caspases inhibits amebic liver abscess formation in a mouse model of disease.

Infection and immunity·2001
Same author

Protective immunity to amebiasis: new insights and new challenges.

The Journal of infectious diseases·2001
Same author

Pathophysiology of amoebiasis.

Trends in parasitology·2001
Same author

Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.

American journal of physiology. Gastrointestinal and liver physiology·2001
Same journal

Immune effector mechanisms in parasitic infections.

Parasitology today (Personal ed.)·2006
Same journal

Nitric oxide in health and disease.

Parasitology today (Personal ed.)·2006
Same journal

Infection, oxford general practice series 40.

Parasitology today (Personal ed.)·2006
Same journal

Parasitism and the platyhelminthes.

Parasitology today (Personal ed.)·2006
Same journal

Reply.

Parasitology today (Personal ed.)·2006
Same journal

Waterborne cryptosporidiosis and the need for legislation.

Parasitology today (Personal ed.)·2006
See all related articles

Amebiasis, a significant global health issue, necessitates new control measures. Research explores recombinant Entamoeba histolytica antigen vaccines as a promising alternative to combat this parasitic infection.

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Vaccinology

Background:

  • Amebiasis, caused by Entamoeba histolytica, is a persistent health concern in developing regions.
  • High rates of amebic dysentery and liver abscesses persist despite existing treatments, indicating a need for novel control strategies.

Purpose of the Study:

  • To review the feasibility of developing a vaccine for amebiasis.
  • To describe recent advancements in recombinant Entamoeba histolytica antigen-based vaccine candidates.

Main Methods:

  • Utilizing recombinant DNA technology to express Entamoeba histolytica antigens.
  • Testing these antigens in prokaryotic systems and animal models for vaccine potential.

Main Results:

Related Experiment Videos

  • Several promising recombinant Entamoeba histolytica antigen-based vaccine candidates have been developed.
  • These candidates include both parenteral and oral formulations.

    • Conclusions:

    • Vaccine development for amebiasis is a feasible and necessary endeavor.
    • Recombinant antigen-based vaccines offer a potential new avenue for controlling invasive amebiasis.